MedPath

A Study to Explore Prognoses of NSCLC Patients Complicated With Oligometastases

Conditions
Non Small Cell Lung Cancer
Registration Number
NCT03427541
Lead Sponsor
Tang-Du Hospital
Brief Summary

An observational study to explore prognoses and clinical treatments of the patients with non-small cell lung cancer complicated with oligometastases

Detailed Description

A multi-centre real-world non-interventional observational study to explore prognoses and clinical treatments of the patients with non-small lung cancer complicated with oligometastases

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
1000
Inclusion Criteria
  • Pathologically diagnosed patients with non-small cell lung cancer;
  • Tumor metastases in one organ (no more than 3 metastases);
Exclusion Criteria
  • Patients with intrapulmonary metastases or multiple primary tumors;
  • Patients with pleural dissemination or invasion of extrapulmonary organs;
  • Patients with supraclavicular lymph node metastasis;
  • Patients with systematic diseases that would influence patient survivals;
  • Patients with no records for visits;

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Overall survival2014 - 2017

Overall survival

Secondary Outcome Measures
NameTimeMethod
Disease-free survival2014 - 2017

Disease-free survival

Trial Locations

Locations (10)

China-Japan Friendship Hospital

🇨🇳

Beijing, Beijing, China

China PLA General Hospital

🇨🇳

Beijing, Beijing, China

Henan cancer hospital

🇨🇳

Zhengzhou, Henan, China

Tongji Hospital Affiliated to Huazhong Technology Hospital

🇨🇳

Wuhan, Hubei, China

Jiangsu cancer hospital

🇨🇳

Nanjing, Jiangsu, China

Xi'an Tangdu Hospital

🇨🇳

Xi'an, Shaanxi, China

Shanghai Chest Hospital

🇨🇳

Shanghai, Shanghai, China

Huaxi Hospital Affiliated to Sichuan University

🇨🇳

Chengdu, Sichuan, China

Tianjin Chest Hospital

🇨🇳

Tianjin, Tianjin, China

First Hospital Affiliated to Zhejiang University

🇨🇳

Hangzhou, Zhejiang, China

China-Japan Friendship Hospital
🇨🇳Beijing, Beijing, China
Deruo Liu, PhD
Principal Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.